Mar. 7 at 12:09 AM
President Trump's recent implementation of tariffs on imports from Mexico, Canada, and China aims to address the fentanyl crisis by pressuring these countries to curb the production and distribution of the drug.
Anticipated Impact on Medication-Assisted Treatment (MAT) Prescriptions
The enforcement of these tariffs is expected to intensify efforts to combat opioid addiction within the United States. This heightened focus could lead to an increase in the demand for Medication-Assisted Treatment (MAT) options, including buprenorphine (Suboxone) and methadone.
Indivior PLC (LON:
$INDV): Specializes in addiction treatment and produces Suboxone (a combination of buprenorphine and naloxone).
Indivior PLC: With a market cap of approximately
$2 billion, Indivior is a mid-cap company. A significant rise in Suboxone prescriptions could positively impact its revenues and, consequently, its stock price.
